🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01248780
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of subcuta...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00265083
Treatments Being Tested
The purpose of this study is to assess the safety of subcutaneous (SC) goli...
Status
Completed
Location
ChanRe Rheumatology And Immunology Center And Research
Start Date
2019-01-07
Trial ID
NCT03733925
Treatments Being Tested
The investigators will perform a 22-week randomized, double-blind, placebo-...
Status
Completed
Location
Reade
Start Date
2013-08
Trial ID
NCT01871649
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00264537
The purpose of this study is to evaluate the safety and effectiveness of go...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT00727987
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00299546
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of golimuma...
Status
Completed
Location
Merck Sharp & Dohme Ltd.
Start Date
2014-05-09
Trial ID
NCT02092285
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00264550
Treatments Being Tested
The purpose of this study is to assess the efficacy of ustekinumab, in adul...
Status
Terminated
Location
Multiple Locations
Start Date
2015-09-03
Trial ID
NCT02437162
Treatments Being Tested